We are live on !
Find out more
Bartlett & Co Portfolio holdings
AUM
$6.16B
Turnover
12.86%
1-Year Est. Return
20.29%
This Fund
S&P 500
This Quarter Est. Return
+10.4%
1 Year Est. Return
+20.29%
3 Year Est. Return
+30.84%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$6.16B
AUM Growth
+$590M
(+11%)
Cap. Flow
+$26M
Cap. Flow % of AUM
Cap. Flow %
0.42%
Top 10 Holdings %
Top 10 Hldgs %
30.5%
Holding
1,314
New
118
Increased
226
Reduced
290
Closed
51
Avg Time Held
3.3
years
Top 10 Avg Time Held
4.2
years
Top 20 Avg Time Held
5.7
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Chevron
CVX
|
+$26.9M |
| 2 |
iShares 1-3 Year Treasury Bond ETF
SHY
|
+$11.7M |
| 3 |
Procter & Gamble
PG
|
+$11M |
| 4 |
McCormick & Company Non-Voting
MKC
|
+$10M |
| 5 |
JPMorgan US Quality Factor ETF
JQUA
|
+$9.04M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Enbridge
ENB
|
+$47.6M |
| 2 |
iShares Core US Aggregate Bond ETF
AGG
|
+$12.7M |
| 3 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$7.97M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$5.21M |
| 5 |
NextEra Energy
NEE
|
+$4.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.28% |
| 2 | Miscellaneous | 17.67% |
| 3 | Healthcare | 12.33% |
| 4 | Financials | 11.49% |
| 5 | Industrials | 9.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
51
iShares Core S&P Small-Cap ETF
IJR
$102B
| $36.4M | 0.59% |
331,255
-238
| -0.1% | -$22.9K |
2013 Q2
42 quarters
|
|
52
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
$25.6B
| $31.9M | 0.52% |
62,051
+18,930
| +44% | +$8.79M |
2013 Q2
42 quarters
|
|
|
53
McCormick & Company Non-Voting
MKC
$12.3B
| $31.4M | 0.51% |
457,395
+152,213
| +50% | +$10M |
2013 Q2
42 quarters
|
|
54
Vanguard Mortgage-Backed Securities ETF
VMBS
$15.6B
| $29.1M | 0.47% |
627,716
-45,041
| -7% | -$1.99M |
2015 Q3
33 quarters
|
|
|
55
iShares Core US Aggregate Bond ETF
AGG
$138B
| $28.4M | 0.46% |
285,425
-133,026
| -32% | -$12.7M |
2013 Q2
42 quarters
|
|
56
iShares 1-5 Year Investment Grade Corporate Bond ETF
IGSB
$23.4B
| $23.9M | 0.39% |
466,308
+81,606
| +21% | +$4.1M |
2013 Q2
42 quarters
|
|
57
Merck
MRK
$354B
| $23.5M | 0.38% |
215,001
+3,723
| +2% | +$386K |
2013 Q2
42 quarters
|
|
58
Automatic Data Processing
ADP
$114B
| $23.3M | 0.38% |
99,559
-1,204
| -1% | -$281K |
2013 Q2
42 quarters
|
|
59
Canadian Pacific Kansas City
CP
$76.1B
| $22.5M | 0.37% |
283,953
-5,906
| -2% | -$432K |
2018 Q4
20 quarters
|
|
60
Walmart Inc
WMT
$942B
| $22M | 0.36% |
416,559
-4,062
| -1% | -$215K |
2013 Q2
42 quarters
|
|
61
Norfolk Southern
NSC
$72.7B
| $20.8M | 0.34% |
88,063
-3,330
| -4% | -$698K |
2013 Q2
42 quarters
|
|
62
Schwab US Broad Market ETF
SCHB
$44.6B
| $20.8M | 0.34% |
1,116,072
-163,635
| -13% | -$2.83M |
2013 Q2
42 quarters
|
|
63
Vanguard Short-Term Bond ETF
BSV
$45.5B
| $20.2M | 0.33% |
262,623
-2,160
| -0.8% | -$164K |
2016 Q3
29 quarters
|
|
64
US Bancorp
USB
$90.1B
| $20M | 0.32% |
452,187
-8,863
| -2% | -$324K |
2013 Q2
42 quarters
|
|
65
AbbVie
ABBV
$500B
| $19.3M | 0.31% |
124,971
+2,049
| +2% | +$299K |
2013 Q2
42 quarters
|
|
66
American Express
AXP
$214B
| $19.1M | 0.31% |
101,818
-2,229
| -2% | -$359K |
2013 Q2
42 quarters
|
|
67
iShares Core MSCI Emerging Markets ETF
IEMG
$152B
| $18.3M | 0.3% |
361,897
+15,567
| +4% | +$754K |
2015 Q4
32 quarters
|
|
68
Danaher
DHR
$158B
| $18.2M | 0.3% |
78,075
-10,594
| -12% | -$2.25M |
2014 Q1
39 quarters
|
|
69
RTX Corp
RTX
$259B
| $17.1M | 0.28% |
202,759
-6,500
| -3% | -$514K |
2013 Q2
42 quarters
|
|
70
Schwab Fundamental US Large Company Index ETF
FNDX
$28.1B
| $17M | 0.28% |
820,698
+19,353
| +2% | +$372K |
2014 Q4
36 quarters
|
|
71
Diageo
DEO
$52B
| $16.1M | 0.26% |
110,432
-5,190
| -4% | -$766K |
2013 Q2
42 quarters
|
|
72
State Street SPDR S&P 500 ETF Trust
SPY
$817B
| $16M | 0.26% |
33,531
-206
| -0.6% | -$91.8K |
2013 Q2
42 quarters
|
|
73
Eli Lilly
LLY
$1.11T
| $15.2M | 0.25% |
26,169
+505
| +2% | +$295K |
2013 Q2
42 quarters
|
|
74
Novartis
NVS
$285B
| $15.1M | 0.25% |
151,046
-2,000
| -1% | -$193K |
2013 Q2
42 quarters
|
|
75
Vanguard FTSE All-World ex-US ETF
VEU
$66.9B
| $14.9M | 0.24% |
266,325
-2,767
| -1% | -$147K |
2013 Q2
42 quarters
|
|
Similar funds
Bartlett & Co's Q4 2023 Portfolio in Review
As of Q4 2023, Bartlett & Co held 1,314 positions worth $6.16B, up 11% from $5.57B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Bartlett & Co's Q4 2023 filing shows 118 new, 226 increased, 290 reduced and 51 closed positions. Its largest new stake was JPMorgan US Quality Factor ETF: 201,376 shares worth $9.7M. The largest sale was Enbridge, an estimated $47.6M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Miscellaneous and Healthcare.
- Bartlett & Co's largest Q4 2023 buy was JPMorgan US Quality Factor ETF: 201,376 shares worth $9.7M.
- Bartlett & Co added most to Chevron in Q4 2023, an estimated $26.9M increase.
- Bartlett & Co's biggest Q4 2023 reduction was Enbridge, cutting an estimated $47.6M.
- Bartlett & Co fully exited Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2023, selling an estimated $7.97M.
- Bartlett & Co's ten largest holdings make up 30% of its $6.16B portfolio in Q4 2023.
- Bartlett & Co opened 118 new positions and closed 51 in Q4 2023.
- Bartlett & Co's portfolio value rose 11% quarter-over-quarter to $6.16B.
Based on Bartlett & Co's 13F filing for Q4 2023, filed 8 Jan 2024.